The Von Willebrand Disease (VWD) Therapeutics Market is expected to register a CAGR of 6% during the forecast period 2021 – 2027. Von Willebrand disease is an inherited bleeding disorder that results from a deficiency or dysfunction of von Willebrand factor (VWF). VWF is a plasma protein that mediates the initial adhesion of platelets at […]